|Bid||22.48 x 1400|
|Ask||0.00 x 800|
|Day's Range||22.36 - 22.89|
|52 Week Range||22.36 - 53.25|
|Beta (3Y Monthly)||1.56|
|PE Ratio (TTM)||5.05|
|Earnings Date||Jul 31, 2019 - Aug 5, 2019|
|Forward Dividend & Yield||1.00 (2.69%)|
|1y Target Est||43.67|
Zacks Value Trader Highlights: General Motors, General Electric, Chemours, Camping World and L Brands
WILMINGTON, Del., May 13, 2019 /PRNewswire/ -- The Society of Chemical Industry (SCI), America Group, announced today that John Sworen, Technical Fellow at The Chemours Company (Chemours) (CC), will be awarded the 2019 SCI Gordon E. Moore Medal. In its sixteenth year, this honor recognizes his contributions in the research and development of non-fluorinated, renewably sourced durable water repellents for use in the consumer textile market.
Opteon™ XL Low GWP Refrigerants Preferred by Carrier Transicold Europe for Transport Refrigeration Ahead of 2021 GENEVA , May 7, 2019 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global ...
The Wilmington, Delaware-based company said it had profit of 55 cents per share. Earnings, adjusted for one-time gains and costs, were 63 cents per share. The results did not meet Wall Street expectations. ...
Continuing to Aggressively Return Capital to Shareholders WILMINGTON, Del. , May 2, 2019 /PRNewswire/ -- First Quarter 2019 Highlights Net Sales of $1.4 billion Net Income of $94 million , with EPS of ...
WILMINGTON, Del., April 30, 2019 /PRNewswire/ -- The Chemours Company (Chemours) (CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today that the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the company's common stock for the second quarter of 2019. The Chemours Company (CC) is a global leader in titanium technologies, fluoroproducts, and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations.
Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
I've been keeping an eye on The Chemours Company (NYSE:CC) because I'm attracted to its fundamentals. Looking at the company as a whole, as a potential stock investment, I believe CC has a lot to offer. Basically, it...
Insider Monkey finished processing more than 700 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of December 31st, 2018. What do these smart investors think about The Chemours Company (NYSE:CC)? The Chemours Company (NYSE:CC) investors should pay attention to a decrease in enthusiasm from smart money […]
WILMINGTON, Del., April 18, 2019 /PRNewswire/ -- The Chemours Company (Chemours) (CC), a global chemistry company with leading market positions in fluoroproducts, today announced a strategic partnership with UniEnergy Technology LLC (UET), a redox flow battery (RFB) manufacturer headquartered in Mukilteo, Washington.
WILMINGTON, Del. , April 11, 2019 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical ...
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! A sizeable part of portfolio returns can be produced by dividend stocks due to their contribution to compounding returns in t...
WILMINGTON, Del., April 2, 2019 /PRNewswire/ -- The Chemours Company ("Chemours") (CC), a global chemistry company with leading market positions in fluoroproducts, titanium technologies, and chemical solutions, received the Fuel Cell PEM Special Contribution Award during the 9th edition of China International New Energy & Intelligent Vehicle Forum 2019 held in Anting, Shanghai. The city of Anting is a key center for the automotive industry in China.
Glenview Capital CEO Larry Robbins speaks at the Sohn Conference on his insurance picks and the stocks he's shorting.
Glenview Capital's Larry Robbins speaks at the Sohn Conference on his insurance picks and the stocks he's shorting.